Drug intelligence / Profile preview

SID1903-R1 + SID1903-R2

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

**SID1903-R1 + SID1903-R2** is a combination of two investigational formulations of the drug SID1903, used in pharmacokinetic studies to assess and compare the safety and pharmacokinetic profiles against the fixed dose combination (FDC) product SID1903. SID1903 itself is a fixed dose combination of **dapagliflozin** (a sodium-glucose co-transporter 2 (SGLT2) inhibitor) and **sitagliptin** (a dipeptidyl peptidase-4 (DPP-4) inhibitor), both of which are oral antidiabetic agents primarily indicated for the management of type 2 diabetes mellitus. The specific composition or role of SID1903-R1 and SID1903-R2 is not detailed beyond being comparator formulations to the fixed combination; both are administered orally in healthy adult volunteers for pharmacokinetic evaluation in clinical studies[1][3][4].

Brand names: SID1903-R1 + SID1903-R2
Other names: SID1903-R1SID-1903-R1SID 1903-R1SID1903-R2SID-1903-R2SID 1903-R2SID1903-R1 + SID1903-R2

Targets

DPP-4 (Dipeptidyl Peptidase-IV)SGLT2 (Sodium-glucose cotransporter protein subunit 2)

Beyond the preview

Go deeper on SID1903-R1 + SID1903-R2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SID1903-R1 + SID1903-R2.

Explore the full profile